New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Bioactive composite supports healing of broken bones

Bioactive composite supports healing of broken bones

by Martina Ohle,Fraunhofer-GesellschaftThe SCABAEGO project scaffold can be customized to fit any size of long bone. With the help of a CT scan of the bone, the scaffold can be tailor-made using
Orthopedics & Sports medicine January 03,2024
Bioactive composite supports healing of broken bones

Bioactive composite supports healing of broken bones

by Martina Ohle,Fraunhofer-GesellschaftThe SCABAEGO project scaffold can be customized to fit any size of long bone. With the help of a CT scan of the bone, the scaffold can be tailor-made using
Orthopedics & Sports medicine January 03,2024
Researchers develop gel to deliver cancer drugs for solid tumors

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show
Oncology January 03,2024
Researchers develop gel to deliver cancer drugs for solid tumors

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show
Oncology January 03,2024
Q&A: Blood tests as an alternative to colonoscopy

Q&A: Blood tests as an alternative to colonoscopy

by Sharon Tregaskis,Columbia University Irving Medical CenterCredit: Karolina Grabowska from PexelsColorectal cancer is the second leading cause of cancer death in the United States. It's al
Q & A January 03,2024
Q&A: Blood tests as an alternative to colonoscopy

Q&A: Blood tests as an alternative to colonoscopy

by Sharon Tregaskis,Columbia University Irving Medical CenterCredit: Karolina Grabowska from PexelsColorectal cancer is the second leading cause of cancer death in the United States. It's al
Q & A January 03,2024
Mathematicians 'thread the needle' to improve IVF success rates

Mathematicians 'thread the needle' to improve IVF success rates

byUniversity of WarwickAlternative OxIVF needle design illustrating lateral orifices for the flushing fluid traveling through the outer lumen to be redirected outwards with the aim of achieving
Genesiology January 03,2024
Mathematicians 'thread the needle' to improve IVF success rates

Mathematicians 'thread the needle' to improve IVF success rates

byUniversity of WarwickAlternative OxIVF needle design illustrating lateral orifices for the flushing fluid traveling through the outer lumen to be redirected outwards with the aim of achieving
Genesiology January 03,2024
FDA approves first at-home test for chlamydia, gonorrhea

FDA approves first at-home test for chlamydia, gonorrhea

by Dennis ThompsonCredit: CC0 Public DomainThe first home test for chlamydia and gonorrhea will soon hit the market, following its approval Wednesday by the U.S. Food and Drug Administration.People wi
Dermatology January 03,2024
FDA approves first at-home test for chlamydia, gonorrhea

FDA approves first at-home test for chlamydia, gonorrhea

by Dennis ThompsonCredit: CC0 Public DomainThe first home test for chlamydia and gonorrhea will soon hit the market, following its approval Wednesday by the U.S. Food and Drug Administration.People wi
Dermatology January 03,2024
Geographical, racial/ethnic differences seen for triple-negative breast cancer

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar
Oncology January 03,2024
Geographical, racial/ethnic differences seen for triple-negative breast cancer

Geographical, racial/ethnic differences seen for triple-negative breast cancer

by Lori SolomonThere are substantial state variations in racial and ethnic disparities in triple-negative breast cancer (TNBC) incidence in the United States, according to a study published online Mar
Oncology January 03,2024
Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer
Oncology January 03,2024
Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer
Oncology January 03,2024
Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu
Oncology January 03,2024
Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers

byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu
Oncology January 03,2024
Prostate cancer testing in Sweden—a study on cost and effectiveness

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,
Oncology January 03,2024
Prostate cancer testing in Sweden—a study on cost and effectiveness

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,
Oncology January 03,2024
Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco
Oncology January 03,2024
Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut

by Katy Bell and Paul Glasziou,The ConversationCredit: AI-generated imageLast week, actors Ryan Reynolds and Rob McElhenney released avideo of themselves getting colonoscopiesto enco
Oncology January 03,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com